Dive into the archives.
- Back online…
Back online… The TDI Web page is finally hosted again at the Structural Genomics Group. We are now working to put online the Kernel for TDI… stay tuned.
- TDI featured in DiarioMedico.com
TDI featured in DiarioMedico.com Today we have been featured at the Spanish main Medical daily journal Diario Médico. You can read more 20110715_DM_page13 (Spanish).
- Yet… more good news for TDI!
We have been awarded a couple of grants! Our research group (Marti-Renom) has been awarded with a Spanish grant to work on RNA target identification for NTDs, which results will end as part of the TDI kernel. Moreover, we will also coordinate a EU grant (a EraNet Pathogenomics) in collaboration with GlaxoSmithKline (LLuís Ballell), Pasteur [...]
- More good news to Open Source Drug Discovery
Mat Todd will be doing “Medicinal Chemistry Without Borders”! Our good friend Mat Todd has been able to coordinate efforts with MMV to optimize lead compounds provided by MMV, while encouraging others around the world to participate. By “others” they mean anybody – undergrads, grads, industry guys. In fact, they will need both medchem advice [...]
- More good news for tropical disease research!
New active compounds against Malaria from the GSK libraries GlaxoSmithKline (GSK) screened nearly 2 million compounds from their chemical library for inhibitors of P. falciparum, of which 13,533 were confirmed to inhibit parasite growth by at least 80% at 2 mM concentration. More than 8,000 also showed potent activity against the multidrug resistant strain Dd2. [...]
- Open Science discussed in Chemistry in Australia
Open Science discussed in Chemistry in Australia Our friend Matthew Todd talks about Open Science in general in this Q & A in the Chemistry in Australia Journal. You can read more here.
- TDI featured in Tropika.net
TDI featured in Tropika.net Tatum Anderson has written a nice piece on Open Source Drug Discovery. She has covered and compared our TDI efforts within a more general OSDD approach. You can read more here.
- Good news for Tropical Disease Research!
New collaboration between Pfizer and DNDi. Pfizer Inc and Drugs for Neglected Diseases initiative (DNDi) have signed an agreement that is designed to facilitate advancements in the battle against human African trypanosomiasis (HAT), visceral leishmaniasis (VL) and Chagas disease, which afflict vulnerable populations in the developing world. Under the agreement, DNDi will have access to [...]
- More on our TDI kernel. Now in PLoS NTD!
PLoS Neglected Tropical Diseases published with full details our kernel. The detailed description on how our The Tropical Disease Initiative kernel was produced have been published in the last issue of the PLoS Neglected Tropical Diseases journal. You can read about it in the PLoS NTD site at this link. For fair use, you can download the PDF here. [...]
- Our TDI kernel has been published!
Nature Biotech published our kernel. The Tropical Disease Initiative kernel has been published in the last issue of the Nature Biotechnology journal as a correspondence to the Editor. You can read about it in the NatBioTech site at this link. The whole kernel will be published soon in the PLoS Neglected Tropical Diseases journal. We’ll [...]
